Rescue of biosynthesis of nicotinamide adenine dinucleotide protects the heart in cardiomyopathy caused by lamin A/C gene mutation
Cardiomyopathy caused by lamin A/C gene (LMNA) mutations (hereafter referred as LMNA cardiomyopathy) is an anatomic and pathologic condition associated with muscle and electrical dysfunction of the heart, often leading to heart failure-related disability. There is currently no specific therapy avail...
Main Authors: | Vignier, N, Chatzifrangkeskou, M, Morales Rodriguez, B, Mericskay, M, Mougenot, N, Wahbi, K, Bonne, G, Muchir, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2018
|
Similar Items
-
Chemical synthesis of the second messenger nicotinic acid adenine dinucleotide phosphate by total synthesis of nicotinamide adenine dinucleotide phosphate.
by: Dowden, J, et al.
Published: (2004) -
ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene
by: Chatzifrangkeskou, M, et al.
Published: (2017) -
A new corrosion-inhibiting strategy for biodegradable magnesium: reduced nicotinamide adenine dinucleotide (NADH)
by: Park, J, et al.
Published: (2018) -
Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery.
by: Kim, Y, et al.
Published: (2008) -
Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutation
by: Chatzifrangkeskou, M, et al.
Published: (2018)